Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-DOXAZOSIN APOTEX INC Resolved 1MG Updated Report 2025-07-18 258169
APO-DONEPEZIL APOTEX INC Resolved 10MG Updated Report 2025-07-18 261167
AURO-TOFACITINIB AURO PHARMA INC Actual shortage 10MG Updated Report 2025-07-18 262863
ATROPINE SULFATE INJECTION USP PFIZER CANADA ULC Actual shortage 1MG Updated Report 2025-07-17 241114
AA-MEDROXY AA PHARMA INC Actual shortage 10MG New Report 2025-07-17 262996
DAXAS ASTRAZENECA CANADA INC Anticipated shortage 500MCG New Report 2025-07-17 262993
APO-METHOTREXATE APOTEX INC Actual shortage 2.5MG New Report 2025-07-17 262990
APO-LANSOPRAZOLE APOTEX INC Actual shortage 30MG Updated Report 2025-07-17 259723
APO-LANSOPRAZOLE APOTEX INC Actual shortage 30MG Updated Report 2025-07-17 260672
APO-TRAZODONE D TABLETS 150MG APOTEX INC Actual shortage 150MG Updated Report 2025-07-17 261629

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SELECT 1/35 (28-DAY) PFIZER CANADA ULC Discontinued 0.035MG 1.0MG Updated Report 2025-07-11 259551
CODEINE 30 LABORATOIRE RIVA INC. To be discontinued 30MG New Report 2025-07-10 262503
ZENHALE ORGANON CANADA INC. To be discontinued 200MCG 5MCG New Report 2025-07-07 262162
ZENHALE ORGANON CANADA INC. To be discontinued 5MCG 100MCG New Report 2025-07-07 262159
PROVERA 10MG TABLETS PFIZER CANADA ULC To be discontinued 10MG New Report 2025-07-07 262135